133 related articles for article (PubMed ID: 14967317)
1. Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates.
Ozdemir FN; Sezer S; Akcay A; Arat Z; Turan M; Gulmus S; Kulah E; Haberal M
Transpl Immunol; 2004 Jan; 12(2):185-8. PubMed ID: 14967317
[TBL] [Abstract][Full Text] [Related]
2. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
3. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
4. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
5. [Panel reactive antibody screening and human leukocyte antigen typing in 1 700 cases of renal transplantation].
Yu LX; Yao B; Ye GR; Du CF; Deng WF; Xu J; Ma JJ; Fu SJ; Xiao LL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):360-2. PubMed ID: 12390747
[TBL] [Abstract][Full Text] [Related]
6. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
7. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.
Lee KW; Kim SJ; Lee DS; Lee HH; Joh JW; Lee SK; Oh HY; Kim DJ; Kim YG; Huh WS; Oh WI; Lee BB
Transplant Proc; 2004 Sep; 36(7):2009-10. PubMed ID: 15518726
[TBL] [Abstract][Full Text] [Related]
8. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
[TBL] [Abstract][Full Text] [Related]
9. Immunological profile of patients awaiting a renal transplant.
Díaz I; Sánchez P; Alonso C; Valdés F
Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955
[TBL] [Abstract][Full Text] [Related]
10. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
[TBL] [Abstract][Full Text] [Related]
12. [Detection of panel-reactive antibody before and after renal transplantation: analysis of 641 cases].
Zhang H; Zhao XB; Wu DL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):852, 855. PubMed ID: 12919918
[TBL] [Abstract][Full Text] [Related]
13. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
Heise E; Manning C; Thacker L
Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
[TBL] [Abstract][Full Text] [Related]
14. Panel reactive antibodies in post-kidney transplantation.
Mongkolsuk T; Sumethkul V; Sujirachato K; Domrongkitchaiporn S; Junpong S; Chiewsilp P
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S52-4. PubMed ID: 9347646
[TBL] [Abstract][Full Text] [Related]
15. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
16. Panel-reactive antibodies late after allograft implantation in children.
Hooper DK; Hawkins JA; Fuller TC; Profaizer T; Shaddy RE
Ann Thorac Surg; 2005 Feb; 79(2):641-4; discussion 645. PubMed ID: 15680851
[TBL] [Abstract][Full Text] [Related]
17. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
18. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens?
Key T; Schuurman HJ; Taylor CJ
Xenotransplantation; 2004 Sep; 11(5):452-6. PubMed ID: 15303982
[TBL] [Abstract][Full Text] [Related]
19. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
